While our results suggest that early and long-term usage of E2 and/or genistein may prevent AD pathologies in aged females via promoting synaptic plasticity, others reported that the mechanism for the closing of the therapeutic window may involve a shift in estradiol receptor (ER) expression (Foster, 2005, 2012; Bean et al., 2014). This evidence concerns the gene ESR1 and Alzheimer disease.